Negative impact largely priced into shares of EpiPen-maker Mylan, analyst says
September 22, 2016 at 16:06 PM EDT
It's "clear that there will be negative impact going forward," but one analyst said the stock has already seen the worst.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.